Form 8-K - Current report:
SEC Accession No. 0001437749-21-002941
Filing Date
2021-02-16
Accepted
2021-02-16 11:07:46
Documents
13
Period of Report
2021-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210215_8k.htm   iXBRL 8-K 29166
  Complete submission text file 0001437749-21-002941.txt   162584

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210211.xsd EX-101.SCH 3700
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210211_def.xml EX-101.DEF 11586
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210211_lab.xml EX-101.LAB 15466
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210211_pre.xml EX-101.PRE 11740
6 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210215_8k_htm.xml XML 2565
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 21634274
SIC: 2834 Pharmaceutical Preparations